Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

Tombak, AnılPepedil Tanrıkulu, FundaDurusoy, Salih SertaçGürkan, EmelKaya, EminÜmit, Elif GülsümFerhanoğlu, BurhanAkpınar, Seval2022-05-112022-05-1120190006-49711528-0020https://doi.org/10.1182/blood-2019-126402https://hdl.handle.net/20.500.11776/881061st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 07-10, 2019 -- Orlando, FL[No Abstract Available]en10.1182/blood-2019-126402info:eu-repo/semantics/openAccessEfficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter StudyConference Object134Q1WOS:000577164606194